This study is accepting new patients by invitation only
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Summary
- Eligibility
- for people ages up to 59 months (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- Links
- NIH Genetics Home Reference related topics: Achondroplasia Description NIH Genetic and Rare Diseases Information Center resources: Achondroplasia
- ID
- NCT03583697
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated